177 related articles for article (PubMed ID: 30520001)
1. Population Pharmacokinetics, Safety and Tolerability of Extended-Release Bupropion and Its Three Metabolites in Chinese Healthy Volunteers.
Zhang F; Li Y; Hu J; Zhong J; Li H
Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):339-352. PubMed ID: 30520001
[TBL] [Abstract][Full Text] [Related]
2. Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations.
Jefferson JW; Pradko JF; Muir KT
Clin Ther; 2005 Nov; 27(11):1685-95. PubMed ID: 16368442
[TBL] [Abstract][Full Text] [Related]
3. Steady-state clinical pharmacokinetics of bupropion extended-release in youths.
Daviss WB; Perel JM; Birmaher B; Rudolph GR; Melhem I; Axelson DA; Brent DA
J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1503-9. PubMed ID: 17135996
[TBL] [Abstract][Full Text] [Related]
4. Single- and multiple-dose pharmacokinetics and tolerability of a paroxetine controlled-release tablet in healthy Chinese subjects
.
Chen R; Shen K; Hu P
Int J Clin Pharmacol Ther; 2017 Mar; 55(3):231-236. PubMed ID: 27936523
[TBL] [Abstract][Full Text] [Related]
5. Tolerability and pharmacokinetics of ranolazine following single and multiple sustained-release doses in Chinese healthy adult volunteers: a randomized, open-label, Latin square design, phase I study.
Tan QY; Li HD; Zhu RH; Zhang QZ; Zhang J; Peng WX
Am J Cardiovasc Drugs; 2013 Feb; 13(1):17-25. PubMed ID: 23355361
[TBL] [Abstract][Full Text] [Related]
6. Steady-state pharmacokinetics of bupropion SR in juvenile patients.
Daviss WB; Perel JM; Rudolph GR; Axelson DA; Gilchrist R; Nuss S; Birmaher B; Brent DA
J Am Acad Child Adolesc Psychiatry; 2005 Apr; 44(4):349-57. PubMed ID: 15782082
[TBL] [Abstract][Full Text] [Related]
7. Single-dose pharmacokinetics of bupropion hydrobromide and metabolites in healthy adolescent and adult subjects.
Oh DA; Crean CS
Clin Pharmacol Drug Dev; 2015 Sep; 4(5):346-53. PubMed ID: 27137143
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and Tolerability of Rufinamide Following Single and Multiple Oral Doses and Effect of Food on Pharmacokinetics in Healthy Chinese Subjects.
Xu M; Ni Y; Zhou Y; He X; Li H; Chen H; Li W
Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):541-8. PubMed ID: 26294172
[TBL] [Abstract][Full Text] [Related]
9. Dose-related reduction in bupropion plasma concentrations by ritonavir.
Park J; Vousden M; Brittain C; McConn DJ; Iavarone L; Ascher J; Sutherland SM; Muir KT
J Clin Pharmacol; 2010 Oct; 50(10):1180-7. PubMed ID: 20484617
[TBL] [Abstract][Full Text] [Related]
10. Effects of woohwangcheongsimwon suspension on the pharmacokinetics of bupropion and its active metabolite, 4-hydroxybupropion, in healthy subjects.
Kim H; Bae SK; Park SJ; Shim EJ; Kim HS; Shon JH; Liu KH; Shin JG
Br J Clin Pharmacol; 2010 Jul; 70(1):126-31. PubMed ID: 20642555
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective Steady-State Disposition and Bioequivalence of Brand and Generic Bupropion in Adults.
Kharasch ED; Neiner A; Kraus K; Blood J; Stevens A; Miller JP; Lenze EJ
Clin Pharmacol Ther; 2020 Nov; 108(5):1036-1048. PubMed ID: 32386065
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of bupropion hydrochloride extended-release versus escitalopram oxalate in Chinese patients with major depressive disorder: Results from a randomized, double-blind, non-inferiority trial.
Shen Y; Zhao Q; Yu Y; Tan Y; Zhang H; Xu X; Wang Z; Li Y; Hu J; Zhong J; Li H
J Affect Disord; 2019 Oct; 257():143-149. PubMed ID: 31301615
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of bupropion and its metabolites in cigarette smokers versus nonsmokers.
Hsyu PH; Singh A; Giargiari TD; Dunn JA; Ascher JA; Johnston JA
J Clin Pharmacol; 1997 Aug; 37(8):737-43. PubMed ID: 9378846
[TBL] [Abstract][Full Text] [Related]
14. Perceptual disturbances associated with low-dose bupropion sustained-release treatment.
Liu CY; Chien YS
J Clin Psychopharmacol; 2007 Oct; 27(5):543-4. PubMed ID: 17873707
[No Abstract] [Full Text] [Related]
15. A Single- and Multiple-Dose Pharmacokinetic Study of Oral Perampanel in Healthy Chinese Subjects.
Jing S; Shiba S; Morita M; Yasuda S; Lin Y
Clin Drug Investig; 2023 Mar; 43(3):155-165. PubMed ID: 36746851
[TBL] [Abstract][Full Text] [Related]
16. Single-dose pharmacokinetics of bupropion in adolescents: effects of smoking status and gender.
Stewart JJ; Berkel HJ; Parish RC; Simar MR; Syed A; Bocchini JA; Wilson JT; Manno JE
J Clin Pharmacol; 2001 Jul; 41(7):770-8. PubMed ID: 11452710
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic Properties and Tolerability of Cycloserine Following Oral Administration in Healthy Chinese Volunteers: A Randomized, Open-Label, Single- and Multiple-Dose 3-Way Crossover Study.
Zhou H; Wu G; Hu X; Zhu M; Zhai Y; Liu J; Shentu J; Wu L
Clin Ther; 2015 Jun; 37(6):1292-300. PubMed ID: 25869627
[TBL] [Abstract][Full Text] [Related]
18. Effect of St. John's wort supplementation on the pharmacokinetics of bupropion in healthy male Chinese volunteers.
Lei HP; Yu XY; Xie HT; Li HH; Fan L; Dai LL; Chen Y; Zhou HH
Xenobiotica; 2010 Apr; 40(4):275-81. PubMed ID: 20102294
[TBL] [Abstract][Full Text] [Related]
19. Rapid clinical induction of bupropion hydroxylation by metamizole in healthy Chinese men.
Qin WJ; Zhang W; Liu ZQ; Chen XP; Tan ZR; Hu DL; Wang D; Fan L; Zhou HH
Br J Clin Pharmacol; 2012 Dec; 74(6):999-1004. PubMed ID: 22519658
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic properties of rosuvastatin after single-dose, oral administration in Chinese volunteers: a randomized, open-label, three-way crossover study.
Li Y; Jiang X; Lan K; Zhang R; Li X; Jiang Q
Clin Ther; 2007 Oct; 29(10):2194-203. PubMed ID: 18042475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
